Maritza Feliz, MD

ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014
ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014
ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014
ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014
ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014
ataxia
ataxia
Acute Cerebellar Ataxia: Successful Treatment With IV Immunoglobulin
11/17/2014
Neha Gupta, MD; Magda Mendez, MD, FAAP; Saurabh Talathi, MD, MPH; Sergey Prokhorov, MD; Maritza Feliz, MD; Naresh Reddivalla, MD
An 8-year-old boy was admitted for evaluation of severe intermittent headache, ataxia, confusion, and slurring of speech.
11/17/2014